Abdominal adiposity in rheumatoid arthritis: Association with cardiometabolic risk factors and disease characteristics

Arthritis and Rheumatism

Volumn 62, Issue 11, 2010, Pages 3173-3182

  Giles, Jon T ^a   Allison, Matthew ^b   Blumenthal, Roger S ^a   Post, Wendy ^a   Gelber, Allan C ^a   Petri, Michelle ^a   Tracy, Russell ^c   Szklo, Moyses ^a   Bathon, Joan M ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; PREDNISONE; RHEUMATOID FACTOR;

ABDOMINAL FAT; ABDOMINAL OBESITY; ADULT; ANTHROPOMETRY; ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; CARDIOVASCULAR RISK; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DRUG EXPOSURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCORING SYSTEM; WAIST CIRCUMFERENCE;

ABDOMINAL FAT; ADIPOSITY; AGE FACTORS; AGED; ARTHRITIS, RHEUMATOID; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; QUESTIONNAIRES; RHEUMATOID FACTOR; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; WAIST CIRCUMFERENCE;

EID: 78249254913     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.27629     Document Type: Article

References (37)

1. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM,. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest 1995; 95: 2409 - 15.
2. Phillips GB, Jing T, Heymsfield SB,. Relationships in men of sex hormones, insulin, adiposity, and risk factors for myocardial infarction. Metabolism 2003; 52: 784 - 90.
3. Lakka HM, Lakka TA, Tuomilehto J, Salonen JT,. Abdominal obesity is associated with increased risk of acute coronary events in men. Eur Heart J 2002; 23: 706 - 13.
4. Shuman WP, Morris LL, Leonetti DL, Wahl PW, Moceri VM, Moss AA, et al. Abnormal body fat distribution detected by computed tomography in diabetic men. Invest Radiol 1986; 21: 483 - 7.
5. Tanko LB, Bagger YZ, Alexandersen P, Larsen PJ, Christiansen C,. Peripheral adiposity exhibits an independent dominant antiatherogenic effect in elderly women. Circulation 2003; 107: 1626 - 31.
6. Walsmith J, Roubenoff R,. Cachexia in rheumatoid arthritis. Int J Cardiol 2002; 85: 89 - 99.
7. Giles JT, Ling SM, Ferrucci L, Bartlett SJ, Andersen RE, Towns M, et al. Abnormal body composition phenotypes in older rheumatoid arthritis patients: association with disease characteristics and pharmacotherapies. Arthritis Rheum 2008; 59: 807 - 15.
8. Ohsuzu F, Kosuda S, Takayama E, Yanagida S, Nomi M, Kasamatsu H, et al. Imaging techniques for measuring adipose-tissue distribution in the abdomen: a comparison between computed tomography and 1.5-tesla magnetic resonance spin-echo imaging. Radiat Med 1998; 16: 99 - 107.
9. Yoon DY, Moon JH, Kim HK, Choi CS, Chang SK, Yun EJ, et al. Comparison of low-dose CT and MR for measurement of intra-abdominal adipose tissue: a phantom and human study. Acad Radiol 2008; 15: 62 - 70.
10. Han TS, Kelly IE, Walsh K, Greene RM, Lean ME,. Relationship between volumes and areas from single transverse scans of intra-abdominal fat measured by magnetic resonance imaging. Int J Obes Relat Metab Disord 1997; 21: 1161 - 6.
11. Giles JT, Szklo M, Post W, Petri M, Blumenthal RS, Lam G, et al. Coronary arterial calcification in rheumatoid arthritis: comparison to the Multi-Ethnic Study of Atherosclerosis. Arthritis Res Ther 2009; 11: R36.
12. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315 - 24.
13. Bild DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, Folsom AR, et al. Multi-Ethnic Study of Atherosclerosis: objectives and design. Am J Epidemiol 2002; 156: 871 - 81.
14. Ling SM, Fried LP, Garrett E, Hirsch R, Guralnik JM, Hochberg MC,. The accuracy of self-report of physician diagnosed rheumatoid arthritis in moderately to severely disabled older women. J Rheumatol 2000; 27: 1390 - 4.
15. Giles JT, Allison M, Bingham CO III, Scott WM Jr, Bathon JM,. Adiponectin is a mediator of the inverse association of adiposity with radiographic damage in rheumatoid arthritis. Arthritis Rheum 2009; 61: 1248 - 56.
16. Blair SN, Haskell WL, Ho P, Paffenbarger RS Jr, Vranizan KM, Farquhar JW, et al. Assessment of habitual physical activity by a seven-day recall in a community survey and controlled experiments. Am J Epidemiol 1985; 122: 794 - 804.
17. Sheehan TJ, Fifield J, Reisine S, Tennen H,. The measurement structure of the Center for Epidemiologic Studies Depression Scale. J Pers Assess 1995; 64: 507 - 21.
18. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C, for the conference participants. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition. Circulation 2004; 109: 433 - 8.
19. Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL,. Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 44 - 8.
20. Fries JF, Spitz PW, Kraines RG, Holman HR,. Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23: 137 - 45.
21. Van der Heijde D,. How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol 2000; 27: 261 - 3.
22. Nettleton JA, Steffen LM, Mayer-Davis EJ, Jenny NS, Jiang R, Herrington DM, et al. Dietary patterns are associated with biochemical markers of inflammation and endothelial activation in the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr 2006; 83: 1369 - 79.
23. Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007; 116: 39 - 48. (Pubitemid 47016245)
24. Sutton-Tyrrell K, Newman A, Simonsick EM, Havlik R, Pahor M, Lakatta E, et al. Aortic stiffness is associated with visceral adiposity in older adults enrolled in the study of health, aging, and body composition. Hypertension 2001; 38: 429 - 33.
25. Rosito GA, Massaro JM, Hoffmann U, Ruberg FL, Mahabadi AA, Vasan RS, et al. Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation 2008; 117: 605 - 13.
26. Mahabadi AA, Massaro JM, Rosito GA, Levy D, Murabito JM, Wolf PA, et al. Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study. Eur Heart J 2009; 30: 850 - 6.
27. Avina-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D,. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 2008; 59: 1690 - 7.
28. Lundgren M, Buren J, Ruge T, Myrnas T, Eriksson JW,. Glucocorticoids down-regulate glucose uptake capacity and insulin-signaling proteins in omental but not subcutaneous human adipocytes. J Clin Endocrinol Metab 2004; 89: 2989 - 97.
29. Galvez BG, San Martin N, Rodriguez C,. TNF-α is required for the attraction of mesenchymal precursors to white adipose tissue in Ob/ob mice. PLoS One 2009; 4: e4444.
30. Bernstein LE, Berry J, Kim S, Canavan B, Grinspoon SK,. Effects of etanercept in patients with the metabolic syndrome. Arch Intern Med 2006; 166: 902 - 8.
31. Marcora SM, Chester KR, Mittal G, Lemmey AB, Maddison PJ,. Randomized phase 2 trial of anti-tumor necrosis factor therapy for cachexia in patients with early rheumatoid arthritis. Am J Clin Nutr 2006; 84: 1463 - 72.
32. Metsios GS, Stavropoulos-Kalinoglou A, Douglas KM, Koutedakis Y, Nevill AM, Panoulas VF, et al. Blockade of tumour necrosis factor-α in rheumatoid arthritis: effects on components of rheumatoid cachexia. Rheumatology (Oxford) 2007; 46: 1824 - 7.
33. Serelis J, Kontogianni MD, Katsiougiannis S, Bletsa M, Tektonidou MG, Skopouli FN,. Effect of anti-TNF treatment on body composition and serum adiponectin levels of women with rheumatoid arthritis. Clin Rheumatol 2008; 27: 795 - 7.
34. Ebina K, Fukuhara A, Ando W, Hirao M, Koga T, Oshima K, et al. Serum adiponectin concentrations correlate with severity of rheumatoid arthritis evaluated by extent of joint destruction. Clin Rheumatol 2009; 28: 445 - 51.
35. Tang CH, Chiu YC, Tan TW, Yang RS, Fu WM,. Adiponectin enhances IL-6 production in human synovial fibroblast via an AdipoR1 receptor, AMPK, p38, and NF-B pathway. J Immunol 2007; 179: 5483 - 92.
36. Westhoff G, Rau R, Zink A,. Radiographic joint damage in early rheumatoid arthritis is highly dependent on body mass index. Arthritis Rheum 2007; 56: 3575 - 82.
37. Roubenoff R, Roubenoff RA, Ward LM, Holland SM, Hellmann DB,. Rheumatoid cachexia: depletion of lean body mass in rheumatoid arthritis: possible association with tumor necrosis factor. J Rheumatol 1992; 19: 1505 - 10.